Item Type | Name |
Academic Article
|
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.
|
Academic Article
|
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
Concept
|
Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Lymphocyte Activation
|
Concept
|
Lymphocyte Depletion
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Lymphocyte Count
|
Concept
|
B-Lymphocyte Subsets
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
B-Lymphocytes
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Epitopes, T-Lymphocyte
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Lymphocyte Subsets
|
Concept
|
T-Lymphocytes
|
Concept
|
Lymphocyte Culture Test, Mixed
|
Concept
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
|
Concept
|
Lymphocyte Transfusion
|
Academic Article
|
Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals.
|
Academic Article
|
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
|
Academic Article
|
IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.
|
Academic Article
|
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.
|
Academic Article
|
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
|
Academic Article
|
Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.
|
Academic Article
|
Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes.
|
Academic Article
|
The immunotherapy of patients with ovarian cancer.
|
Academic Article
|
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
|
Academic Article
|
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.
|
Academic Article
|
Correspondence re R. Lapointe et al., CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 2003;63:2836-43.
|
Academic Article
|
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
|
Academic Article
|
IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells.
|
Academic Article
|
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.
|
Academic Article
|
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
|
Academic Article
|
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.
|
Academic Article
|
Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses.
|
Academic Article
|
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
|
Academic Article
|
The use of gene-modified tumor-infiltrating lymphocytes for cancer therapy.
|
Academic Article
|
Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acid.
|
Academic Article
|
The development of gene therapy for the treatment of cancer.
|
Academic Article
|
Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.
|
Academic Article
|
Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
|
Academic Article
|
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.
|
Academic Article
|
CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.
|
Academic Article
|
Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
|
Academic Article
|
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma.
|
Academic Article
|
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.
|
Academic Article
|
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
|
Academic Article
|
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
|
Academic Article
|
Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses.
|
Academic Article
|
Antitumor activity of dual-specific T cells and influenza virus.
|
Academic Article
|
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.
|
Academic Article
|
T helper 17 cells promote cytotoxic T cell activation in tumor immunity.
|
Academic Article
|
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
|
Academic Article
|
2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.
|
Academic Article
|
Immunotherapy of melanoma: an update.
|
Academic Article
|
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
|
Academic Article
|
Induction of TLR4-dependent CD8+ T cell immunity by murine ?-defensin2 fusion protein vaccines.
|
Academic Article
|
Antitumor activity mediated by CpG: the route of administration is critical.
|
Academic Article
|
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
|
Academic Article
|
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
|
Academic Article
|
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency.
|
Academic Article
|
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-? inducible chemokines.
|
Academic Article
|
Advances in the development of cancer immunotherapies.
|
Academic Article
|
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
|
Academic Article
|
Persistent antigen at vaccination sites induces tumor-specific CD8? T cell sequestration, dysfunction and deletion.
|
Academic Article
|
Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
|
Academic Article
|
Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.
|
Academic Article
|
Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen.
|
Academic Article
|
The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
|
Academic Article
|
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
|
Academic Article
|
Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
|
Academic Article
|
Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
|
Academic Article
|
Current challenges in cancer gene therapy.
|
Academic Article
|
A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen.
|
Academic Article
|
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.
|
Academic Article
|
CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells.
|
Academic Article
|
CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
|
Academic Article
|
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
|
Academic Article
|
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6.
|
Academic Article
|
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
|
Academic Article
|
Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
|
Academic Article
|
Overexpression of interleukin 21 induces expansion of hematopoietic progenitor cells.
|
Academic Article
|
Less yin, more yang: confronting the barriers to cancer immunotherapy.
|
Academic Article
|
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses.
|
Academic Article
|
Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.
|
Academic Article
|
Detection and characterization of a novel subset of CD8?CD57? T cells in metastatic melanoma with an incompletely differentiated phenotype.
|
Academic Article
|
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
|
Academic Article
|
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.
|
Academic Article
|
Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.
|
Academic Article
|
A new approach to simultaneously quantify both TCR a- and ?-chain diversity after adoptive immunotherapy.
|
Academic Article
|
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
|
Academic Article
|
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
|
Academic Article
|
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
|
Academic Article
|
Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.
|
Academic Article
|
Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.
|
Academic Article
|
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens.
|
Academic Article
|
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
|
Academic Article
|
Summary of the primer on tumor immunology and the biological therapy of cancer.
|
Academic Article
|
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
|
Academic Article
|
The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity.
|
Academic Article
|
Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
|
Academic Article
|
Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer.
|
Academic Article
|
Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature.
|
Academic Article
|
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
|
Academic Article
|
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer.
|
Academic Article
|
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
|
Academic Article
|
Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.
|
Academic Article
|
Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.
|
Academic Article
|
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.
|
Academic Article
|
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.
|
Academic Article
|
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.
|
Academic Article
|
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
|
Academic Article
|
Novel Treatments in Development for Melanoma.
|
Academic Article
|
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
|
Academic Article
|
Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
|
Academic Article
|
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
|
Academic Article
|
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity
|
Academic Article
|
Defective STAT1 activation associated with impaired IFN-η production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2
|
Academic Article
|
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma
|
Academic Article
|
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
|
Academic Article
|
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
|
Academic Article
|
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
|
Academic Article
|
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
|
Academic Article
|
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
|
Academic Article
|
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
|
Academic Article
|
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.
|
Academic Article
|
Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Defective STAT1 activation associated with impaired IFN-? production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
|
Academic Article
|
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity.
|
Academic Article
|
Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.
|
Academic Article
|
Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
|
Academic Article
|
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.
|
Academic Article
|
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade.
|
Academic Article
|
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
|
Academic Article
|
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
Academic Article
|
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
|
Academic Article
|
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
|
Academic Article
|
Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases.
|
Academic Article
|
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.
|
Academic Article
|
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.
|
Academic Article
|
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
|
Academic Article
|
A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes.
|
Academic Article
|
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.
|
Academic Article
|
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.
|
Academic Article
|
T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.
|
Academic Article
|
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
|
Academic Article
|
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
|
Academic Article
|
RNA editing derived epitopes function as cancer antigens to elicit immune responses.
|
Academic Article
|
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.
|
Academic Article
|
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
|
Academic Article
|
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
|
Academic Article
|
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2R??-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors.
|
Academic Article
|
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3K? Inhibition in PTEN Loss Melanoma.
|
Academic Article
|
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
|
Academic Article
|
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.
|
Academic Article
|
B cells and tertiary lymphoid structures promote immunotherapy response.
|
Academic Article
|
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
|
Academic Article
|
Comprehensive T cell repertoire characterization of non-small cell lung cancer.
|
Academic Article
|
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
|
Academic Article
|
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02).
|
Academic Article
|
Bone morphogenetic protein 7 promotes resistance to immunotherapy.
|
Academic Article
|
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
|
Academic Article
|
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
|
Academic Article
|
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer.
|
Academic Article
|
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators.
|
Academic Article
|
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling.
|
Academic Article
|
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
|
Academic Article
|
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
|
Academic Article
|
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
|
Academic Article
|
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
|
Academic Article
|
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
|
Academic Article
|
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-? signaling.
|
Academic Article
|
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
|
Academic Article
|
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
|
Academic Article
|
A novel retinoic acid receptor-? agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
|
Academic Article
|
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
|